| Robert T. | Abbott | President & CEO | Onkor Pharmaceuticals |
| John F. | Alderete, PhD | Professor & Associate Director, School of Molecular Bioscience | Washington State University |
| David | Basiji | President and CEO | Amnis Corporation |
| Sharon | Busby | Former Team Leader | Zymogenetics |
| John | Castle | Lecturer in Entrepreneurship | University of Washington |
| Tom | Clary | President | The Inception Group |
| Howard C. | Coleman | Chairman & CEO | Genelex Corporation |
| Richard | Daifuku | Partner | Phase 1two3 |
| James | Davie | President | Blood Cell Storage, Inc. |
| Sam | Deliganis | President & CEO | NW Pharmaceutical Research |
| Charles | Emery | Principal System Engineer, Supply Chain | Phillips Healthcare |
| Martha | Feldman | President | Drug & Device Development Company, Inc. |
| James H. | Gilbert | Former Senior Director, Biopharmaceuticals | MDS Pharma Services |
| Gail E. | Gillenwater, Ph.D. | Principal | Pharma Development Solutions |
| Doug | Hansmann | Chief Operating Officer | EKOS Corporation |
| Daniel | Hawkins | Founder | Calibra Medical |
| Karen | Hedine | President & CEO | Micronics, Inc. |
| Catherine | Hennings | Senior Commercialization Advisor | PATH (Program for Appropriate Technology in Health) |
| Lee | Hooks | CEO | Axio Research LLC |
| Bruce | Jackson | Business Development Manager-Life Sciences | enterpriseSeattle |
| Jim | Karkanias | Sr. Director, Applied Research and Technologies | Microsoft |
| Glenn | Kawasaki | CEO | Accium BioSciences, Inc. |
| Peter | Knudson | Partner | Woodcock Washburn LLP |
| Beatrice | Langton-Webster | President | BC Associates |
| Jean-Pierre | Laurent | Principal | Pacific Horizon Ventures |
| Spencer | Lemons | Founder and Managing Partner | Spira Consulting LLC |
| Tim | McAfee, MD, MPH | Chief Medical Officer | Free & Clear |
| James A. | Nelson, MD | Partner | Integra Ventures |
| Robert | Overell | President | PhaseRx Pharmaceuticals |
| Todd | Patrick | Retired | ID Biomedical |
| Christopher H. | Porter | CEO | Medical Genesis |
| Erick | Rabins | Sr VP for Strategic Affairs | C3 Jian, Inc. |
| J. Thomas | Ranken | Principal | Ranken Consulting |
| Roger | Sahm, MD | Consultant | |
| Lucy | Sannes, PhD | President | Sannes & Associates, Inc. |
| Nelson | Schneider | Retired | Wall Street biotechnology analyst |
| Thomas | Schulte, Ph.D. | VP, Research | Pelikan Technologies, Inc. |
| Gary | Schweikhardt | Chairman | Washington Biotechnology Funding, Inc. |
| James | Severson | Owner, Consultant | Pinnacle Reach LLC |
| Lisa G. | Shaffer, PhD | President & CEO | Signature Genomic Laboratories |
| Tom | Simpson | Managing Partner | Northwest Venture Associates |
| Christopher | Somogyi | Senior Strategist | Intellectual Ventures |
| Ronald Michael | Thomas | Technology Commmercialization Manager | Battelle, PNWD/PNNL |
| Michael | Tippie | VP Business Development | Eureka Genomics |
| Glynn | Wilson | Principal | GW Group |
Modified: 05/03/10